B2P-31117-38074
4 vaccinations
2 coded responses
53 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 220 / VA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Muscle or body achesAdult check-in
- 2021-04-05
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-25
- 2021-10-22
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-06
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Muscle or body achesAdult check-in
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
-
2022-03-02
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Tiredness, weakness, upset stomach, neausa, gas, loss of appetite; have not taken a test to verify but symptoms are almost certainly due to pregnancy.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, runny rose, congestion, coughing, fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-20
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-12-19
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 3 months, dose 3
Symptoms: Tiredness, weakness, upset stomach, neausa, gas, loss of appetite; have not taken a test to verify but symptoms are almost certainly due to pregnancy.
Release 11 — 6 months, dose 3
Symptoms: Sore throat, runny rose, congestion, coughing, fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release